Hoth Therapeutics, Inc. — Director's Dealing 2019

Mar 4, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2019-02-14

Reporting Person: Poor Kevin Jess (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Convertible Preferred Stock	$		Common Stock (750000)		Direct
Warrants	$1.00	2024-10-25	Common Stock (187500)		Direct

Footnotes

F1: The Series A Convertible Preferred Stock have no expiration date and are convertible, at the option of the holder, into shares of common stock of the Issuer at the then-effective conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Articles of Incorporation (as amended, the "Articles of Incorporation")). The shares of Series A Convertible Preferred Stock will automatically convert into shares of common stock at the then-effective conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Articles of Incorporation) immediately prior to the closing of the Issuer's initial public offering.

F2: The Series A Convertible Preferred Stock is convertible into shares of the Issuer's common stock at a 1-for-1 conversion rate.